文献速递生殖医学

选择性生育力保存:一项关于卵母细胞冷冻保存趋势及5至7年随访期内卵母细胞利用情况的国家数据库研究

Elective fertility preservation: a national database study on trends in oocyte cryopreservation and oocyte utilization over a 5- to 7-year follow-up period.
PubMed 文献 · Am J Obstet Gynecol · 2025-08-29

该回顾性队列研究基于2014至2021年SART CORS数据,分析计划性卵母细胞冷冻保存的趋势及后续卵母细胞复苏利用情况。结果显示冷冻周期数从2014年4153例增至2021年16436例,平均年龄从36.0岁降至34.9岁;2014至2016年冷冻者在5至7年内仅5.7%返回复苏,复苏者累计活产率为28.9%。

要点

  • 计划性卵母细胞冷冻保存周期数从2014年4153例增至2021年16436例(P<.01),平均年龄从36.0岁降至34.9岁(P<.01)。
  • 2014至2016年冷冻者在5至7年随访期内仅852例(5.7%)返回复苏卵母细胞。
  • 复苏者中78.5%获得可用胚胎,累计活产率为28.9%,活产率随冷冻时年龄增加而下降。

核心结论

  • 计划性卵母细胞冷冻保存自获得报告以来呈指数增长,冷冻时平均年龄下降。
  • 5至7年随访期内返回复苏卵母细胞的比例低,大部分冷冻卵母细胞未被使用。
  • 冷冻时年龄较大者更可能返回且间隔更短,返回者结局令人安心但每周期产出率很低。

研究设计与样本

  • 回顾性队列研究,数据来自2014至2021年向SART CORS报告的所有因生育力保存仅行自体卵母细胞冷冻的患者及所有关联的卵母细胞复苏周期。
  • 统计分析采用线性回归检验。

主要发现

  • 计划性卵母细胞冷冻患者数从2014年4153例增至2021年16436例(P<.01),平均年龄从36.0岁降至34.9岁(P<.01)。
  • 2014至2016年冷冻者在5至7年随访期内仅852例(5.7%)返回复苏卵母细胞。
  • 返回复苏者中78.5%(n=669)获得可用胚胎,21.5%(n=183)无可用胚胎。
  • 有可用胚胎者中64.2%(n=547)行新鲜胚胎移植,46.1%(n=393)有胚胎冷冻,仅14.3%(n=122)选择全胚冷冻。
  • 393例冷冻胚胎者中115例(29.3%)返回行冻融胚胎移植;所有复苏者累计活产率为28.9%,活产率随冷冻时年龄增加而下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2012, oocyte cryopreservation was no longer deemed experimental by the American Society of Reproductive Medicine. Since then, awareness and utilization of planned oocyte cryopreservation have become much more widespread. However, little is known regarding current national trends and the rate of warming and utilization of cryopreserved oocytes. OBJECTIVE: To assess national trends in planned oocyte cryopreservation, subsequent oocyte utilization, and outcomes of oocyte warming cycles. STUDY DESIGN: Retrospective cohort study with data from all patients reported to the Society for Assisted Reproductive Technology Clinic Outcome Reporting System undergoing cryopreservation of autologous oocytes for fertility preservation only between the years 2014 and 2021 and all linked oocyte warming cycles. Statistical analyses were performed using linear regression tests. RESULTS: The number of patients undergoing planned oocyte cryopreservation has increased exponentially, with 4153 patients in 2014 compared to 16,436 in 2021 (P<.01). There is a decrease in the age of patients undergoing planned oocyte cryopreservation over time, with a mean age of 36.0 years in 2014 compared to 34.9 years in 2021 (P<.01). Subsequent return for utilization of cryopreserved oocytes within a 5- to 7-year follow-up period from planned oocyte cryopreservation cycles occurring between 2014 and 2016 was low, with only 852 patients (5.7%) returning for oocyte warming. The likelihood of returning increased with advancing patient age at the time of oocyte cryopreservation, while the mean time to oocyte warming significantly decreased with increasing patient age at the time of oocyte cryopreservation, except in patients >42 years (P<.01). Of patients who returned for oocyte warming, 78.5% (n=669) obtained a usable embryo, while 21.5% (n=183) had no usable embryos. Of those with usable embryos, 64.2% (n=547) had a fresh embryo transfer, 46.1% (n=393) had embryos for cryopreservation, and only 14.3% of patients (n=122) opted for a freeze-all approach. Of the 393 patients with cryopreserved embryos, 115 (29.3%) returned for a frozen embryo transfer. The cumulative live birth rate of all patients undergoing oocyte warming was 28.9%, with live birth rate decreasing with an increasing age at the time of oocyte cryopreservation. CONCLUSION: Since the availability of oocyte cryopreservation reporting for fertility preservation only, planned oocyte cryopreservation has increased exponentially. Mean age at the time of oocyte retrieval has decreased, reflecting interest in the procedure among younger patients, but there has been minimal change in distribution by race/ethnicity and geographic region. Despite the increase in oocyte cryopreservation, return for oocyte warming over a 5- to 7-year follow-up period was low, with a substantial portion of cryopreserved oocytes remaining unused. Patients who were older at the time of oocyte cryopreservation were more likely to return and had a shorter interval between oocyte cryopreservation and warming. Although rates of oocyte warming are low, the outcomes for patients who do return to use cryopreserved oocytes are reassuring. Most patients have a usable embryo after oocyte warming and the live birth rates are reassuring and demonstrate an expected age-related decline. However, given the low return rate, the yield on a per-planned oocyte cryopreservation cycle is very low.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee MB, Siavoshi M, Kwan L, et al. Elective fertility preservation: a national database study on trends in oocyte cryopreservation and oocyte utilization over a 5- to 7-year follow-up period. Am J Obstet Gynecol. 2025. PMID: 40886784. doi:10.1016/j.ajog.2025.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。